Netflix’s international streaming subscriber base will reach 140 million by 2025, according to a research note by L&F Capital Management.The US-based boutique equity investment group claims that by 2025 Netflix’s international subscriber count will include 55 million customers from Europe and almost 45 million from Asia.“In short, we think the international total addressable market (TAM) is just over 750 million households, and believe NFLX can net 140 million international streaming subs by 2025,” said L&F in a note published on finance site Seeking Alpha.In Europe the research identifies Germany, France, the UK and Italy as the biggest potential markets – where it claims Netflix has seen “mixed success thus far” – and says Europe’s addressable market by 2025 will be 225 million households.Asia, excluding China, will hold even more opportunity with an estimated addressable market of some 290 million homes. India and Japan, where Netflix has already announced original content plans, are the biggest addressable markets in this region, according to L&F.In the Americas, the research estimates that Netflix can target a total market of roughly 120 million households, with Brazil and Mexico the biggest potential markets.In Africa the market opportunity will be roughly 85 million homes and ”given urbanisation and population size, we think the Africa market is bigger than both the Middle East and Oceania,” said L&F.In its first quarter earnings announcement Netflix reported that it had 34.53 million total international streaming members, and 46.97 million in the US.Netflix said it expected to add 2.5 million members in the second quarter of 2016 – 2.0 million internationally and 500,000 in the US.
M6 has invested in a new digital terrestrial TV (DTT) station that is due to launch in the Ivory Coast in 2018 called Life TV.M6 chairman Nicolas De Tavernost and Voodoo Group CEO Fabrice SawegnonLife TV will be a general interest channel with a varied programme schedule spanning entertainment, news, films and talk-shows.The channel will broadcast local content, produced in-house in a new production studio, as well as programmes from the M6 Group library.M6 has acquired a 33% stake of Life TV and will collaborate on the project with Fabrice Sawegnon, CEO of Ivory Coast communications company, Voodoo Group.Vincent Broussard, who has led several television channels in France, including Teva, TF6 and Serieclub, will be CEO of Life TV.“By joining forces with Fabrice Sawegnon, founder of Voodoo Group, with this equity investment the group is entering Africa via an Ivorian market poised for significant growth and confirms its position as a major player in French-speaking TV,” said M6 in a statement.“This agreement is in line with the proactive policy of risk taking and innovation implemented by M6 Group since its creation.”
The Tower MuseumA new programme aimed at helping visually impaired visitors to access information at the Tower Museum will be launched tomorrow.From Wednesday, February, 3, the Discovery Pen Programme will allow those with limited vision to access detailed audio descriptions of the objects on display in the Story of Derry exhibition.Speaking ahead of the launch, Mayor of Derry City and Strabane District, Councillor Elisha McCallion, said the new audio aids would be a fantastic resource at the Museum.“I am delighted that Derry City and Strabane District Council is introducing the Discovery Pen Programme at the Tower Museum. The pens will really bring the exhibition to life for those whose visitor experiences are limited and allow them to access all the information they need to enjoy the Story of Derry.“I hope that the pens will really make a difference to anyone visiting the exhibition who is visually impaired.” ShareTweet Education Officer with the Tower Museum, Margaret Edwards, said: “Our primary aim at the Museum is to make the story of the city open and accessible to all, and with the new Discovery Pens we can now make the exhibition even more inclusive.“I think that the pens will be an extremely useful resource and will open up the museum to new audiences.”Shaun Canny from the Royal National Institute for the Blind will join the Mayor to launch the Discovery Pens and will examine the benefits of the programme before a short demonstration of how to use them.The event is free and takes place on Wednesday February 3rd at 10am. Anyone interested in attending should RSVP to email@example.com TOWER TO LAUNCH NEW DISCOVERY PEN PROGRAMME TOWER TO LAUNCH NEW DISCOVERY PEN PROGRAMME was last modified: February 2nd, 2016 by John2John2 Tags:
Source:https://www.upmc.com/media/news/102018-emens-nejm-trial Reviewed by James Ives, M.Psych. (Editor)Oct 23 2018Patients with an aggressive form of advanced breast cancer can benefit from immunotherapy when used in combination with chemotherapy as first-line treatment, according to the results of a large international Phase III clinical trial published today in the New England Journal of Medicine and led by a researcher at the UPMC Hillman Cancer Center and the University of Pittsburgh School of Medicine.The study is the first large clinical trial to support the use of immunotherapy in treating triple-negative breast cancer and establishes a new standard of care in PD-L1+ patients, senior trial investigator and study author Leisha Emens, M.D., Ph.D., co-leader of the UPMC Hillman Cancer Immunology and Immunotherapy Program, explained. Results were presented today at the annual meeting of the European Society for Medical Oncology in Munich, Germany.Breast cancer is the most common cancer in women, with an estimated 2 million new cases diagnosed in 2018 alone. About 10 to 20 percent of patients have triple-negative breast cancer, an aggressive form of breast cancer that has a higher chance of recurrence and metastasis, and lower survival.”While chemotherapy is the current standard of treatment for triple-negative breast cancer, there is an urgent need for newer, more effective therapies,” said Emens. “The results of this trial showed that adding the immunotherapy drug atezolizumab to chemotherapy was well-tolerated and resulted in a clear increase in clinical benefit for some patients with triple-negative breast cancer.”The IMpassion130 trial was designed to evaluate whether atezolizumab, approved by the U.S. Food and Drug Administration to treat both bladder cancer and non-small cell lung cancer, could be used along with chemotherapy to improve clinical outcomes in patients with triple-negative breast cancer. Atezolizumab belongs to a class of immunotherapy medications known as checkpoint inhibitors. The drug targets the PD-L1 protein, which in triple-negative breast cancer patients is found mostly on immune cells that infiltrate the tumor. Blocking PD-L1 reinvigorates these immune cells, allowing them to attack the tumor.The trial enrolled 902 patients with either metastatic or locally advanced triple-negative breast cancer that could not be surgically removed. Patients were enrolled at 246 sites in 41 countries across the world and were randomly assigned to receive either atezolizumab or a placebo, along with the chemotherapy drug nab-paclitaxel.Related StoriesUsing machine learning algorithm to accurately diagnose breast cancerLiving with advanced breast cancerAI-enabled device detects if targeted chemotherapy is workingBoth progression-free survival–the length of time the patient lives after receiving the therapy without the tumor growing or spreading, and overall survival–the length of time the patient survives from the start of the trial, were recorded.In the overall patient population, the researchers found a statistically significant increase in progression-free survival in patients treated with both nab-paclitaxel and atezolizumab – 7.2 months when compared to 5.5 months in patients who received chemotherapy alone. In the group of patients who expressed the PD-L1 protein on tumor-infiltrating immune cells, the combination treatment had a more significant impact on progression-free survival – 7.5 months versus 5 months.Overall survival was 21.3 months in the combination treatment group as compared to 17.6 months with chemotherapy alone, though this did not reach statistical significance in this first analysis. In the group of patients who expressed PD-L1 on their tumors, the difference in survival was greater, with overall survival of 25 months, in contrast to 15.5 months in patients treated with nab-paclitaxel alone.”This improvement in progression-free and overall survival is clinically meaningful in patients with advanced PD-L1+ triple-negative breast cancer,” Emens said. The researchers continue to follow the patients to determine overall survival over a longer time period.The adverse events observed were similar to the known adverse event profile of the two drugs. Patients who received both immunotherapy and nab-paclitaxel experienced a higher frequency of adverse events that were potentially immune-related, than those who received chemotherapy alone, at 7.5 percent versus 4.3 percent, respectively.The trial was funded by F. Hoffmann-La Roche/Genentech, which provided atezolizumab and placebo and collaborated with an academic steering committee regarding the trial design and data collection, analysis and interpretation. Celgene provided nab-paclitaxel and had no role in the trial design, data collection or analysis, but did review the manuscript.A complete listing of the authors and their affiliations, along with the financial disclosure forms provided by the authors can be found with the article online.
Reviewed by James Ives, M.Psych. (Editor)Nov 7 2018Researchers at the University of Waterloo have developed a new system that could significantly speed up the discovery of new drugs and reduce the need for costly and time-consuming laboratory tests.The new technology called Pattern to Knowledge (P2K) can predict the binding of biosequences in seconds and potentially reduce bottlenecks in drug research.P2K uses artificial intelligence (AI) to leverage deep knowledge from data instead of relying solely on classical machine learning.”P2K is a game changer given its ability to reveal subtle protein associations entangled in complex physiochemical environments and powerfully predict interactions based only on sequence data,” said Andrew Wong, professor, Systems Design Engineering, and Founding Director, Centre for Pattern Analysis and Machine Intelligence (CPAMI). “The ability to access this deep knowledge from proven scientific results will shift biological research going forward. P2K has the power to transform how data could be used in the future.”Related StoriesBridging the Gaps to Advance Research in the Cannabis IndustryOlympus Europe and Cytosurge join hands to accelerate drug development, single cell researchScientists develop universal FACS-based approach to heterogenous cell sorting, propelling organoid researchAlthough a large amount of biological sequence data has been collected, extracting meaningful and useful knowledge hasn’t been easy. P2K algorithms tackle this challenge by disentangling multiple associations to identify and predict amino acid bindings that govern protein interactions. Since P2K is much faster than existing biosequence analysis software with almost 30 per cent better prediction accuracy, it could significantly speed up the discovery of new drugs. By drawing information from databases in the Cloud, P2K could predict how tumor proteins and potential cancer treatments would interact.Although still in the early prototype stage, Professor Wong and his team have made the online P2K system available publicly to researchers to start identifying new bio-sequence interactions.”Putting this AI technology in the hands of biomedical researchers will generate immediate results, which could be used for future scientific discoveries,” said Antonio Sze-To, research associate, Systems Design Engineering, and co-inventor of P2K.Since it analyzes sequential data, the applicability of P2K isn’t limited to biomedical research. P2K could benefit the financial industry by making useful associations and predictions for smart trading or the cybersecurity sector by predicting the likelihood of a potential cyber attack.Source: https://uwaterloo.ca/
Patients typically live to 20 or 30 years of age. There have been important improvements in respiratory care, which used to be what a majority of patients would succumb to. Now, in their 20s and 30s, they’re often succumbing to cardiomyopathy. The heart is functioning with a major component of the cell membrane missing. Over time, it wears out.”Lead author Michelle Parvatiyar, an assistant professor in the Department of Nutrition, Food and Exercise Sciences in FSU’s College of Human Sciences The study was part of continued efforts by UCLA biologist Rachelle H. Crosbie, the study’s corresponding author, who previously identified sarcospan as a protein that could improve mechanical support in skeletal cell membranes lacking dystrophin. Her finding buoyed DMD researchers and affirmed sarcospan’s potential as an effective tool in the fight against the condition.”But nobody had really looked at how increasing the levels of this protein might affect the heart,” Parvatiyar said.Using a unique mouse model with a dearth of dystrophin, Parvatiyar and her collaborators did just that.In their study, the team found that while it’s is not a like-for-like replacement for dystrophin, an overexpression of sarcospan in cardiac cells seems to do the job of stabilizing cell membranes. Even under stress, researchers found, sarcospan overexpression was able to improve the membrane defect in dystrophin-deficient cells.”Sarcospan doesn’t quite do the job of dystrophin, but it acts as a glue to stabilize the membrane and hold protein complexes together when dystrophin is lacking,” said Parvatiyar, explaining a concept developed by Crosbie.Related StoriesWhy Mattresses Could be a Health Threat to Sleeping ChildrenNew network for children and youth with special health care needs seeks to improve systems of careResearchers identify gene mutations linked to leukemia in children with Down’s syndromeCardiac measurements confirmed that sarcospan does protect the cell membrane even when the heart is placed under stress. Study co-author and FSU College of Medicine Associate Professor Jose Pinto performed the measurements, along with FSU graduate student Karissa Dieseldorff Jones and University of Miami Miller School of Medicine research assistant Rosemeire Takeuchi Kanashiro.In addition to serving as a kind of stabilizing glue, researchers said sarcospan could also act as a scaffold that supports other essential proteins at the cell membrane. That function could allow sarcospan to carry mini versions of dystrophin -; which, in its normal state, has a long and unwieldy genetic code -; to the edges of cardiac cells, where they could buttress the fragile membranes.”The idea is that you could administer the sarcospan and the dystrophin at the same time, and the sarcospan could facilitate mini dystrophin localizing to the cell membrane and help hold those complexes in place,” Parvatiyar said.Sarcospan’s two possible functions could augment existing DMD treatments, Parvatiyar said, or they could give rise to novel therapies that fortify weakened cardiac cell membranes and improve the quality of life for people with DMD.In her previous position at UCLA, Parvatiyar had frequent interactions with DMD patients and their families. She said these interactions, and the unshakeable hope she’s witnessed in those suffering from DMD, continue to drive her and her colleagues in the search for new ways to combat this debilitating condition.”Those were the first times in my life I’d ever had someone come up to me and thank me for my work,” she said. “Sometimes you can feel removed from it in the laboratory day after day. You see incremental progress. But to see people who are really yearning for help is motivating. Their positivity is incredibly inspiring.”Source:Florida State UniversityJournal reference:Parvatiyar, M.S. et al. (2019) Stabilization of the cardiac sarcolemma by sarcospan rescues DMD-associated cardiomyopathy. JCI Insight. doi.org/10.1172/jci.insight.123855. Reviewed by James Ives, M.Psych. (Editor)Jun 16 2019A new multi-institution study spearheaded by researchers at Florida State University and the University of California, Los Angeles suggests a tiny protein could play a major role in combating heart failure related to Duchenne muscular dystrophy (DMD), the most common lethal genetic disorder among children.In collaboration with scientists from across the nation, FSU researchers found that increased levels of the protein sarcospan improve cardiac function by reinforcing cardiac cell membranes, which become feeble in patients with DMD.Their findings were published in the journal JCI Insight.The condition, which typically afflicts young boys, is caused by a mutation that prevents the body from producing dystrophin, a protein crucial to the health of skeletal, respiratory and cardiac muscles. Advances in treatment for certain types of DMD-related muscle degradation have helped to prolong patients’ lifespans. However, as DMD patients age, their heart function declines dramatically.
Reporters take pictures of a Nissan Sylphy Zero Emission, the Nissan’s first all-electric vehicle built in China, at the Nissan factory in Guangzhou, Guangdong province, China, Monday, Aug. 27, 2018. The Sylphy is part of a wave of dozens of electric models planned by global automakers for China where the government is pressing them to accelerate development of the technology. (AP Photo/Vincent Yu) A worker of Dongfeng Nissan, right, wears a uniform with a pin with Chinese words “Communist party member” attends the ceremony of launching Nissan Sylphy Zero Emission, the Nissan’s first all-electric vehicle built in China, in Guangzhou, Guangdong province, China, Monday, Aug. 27, 2018. The Sylphy is part of a wave of dozens of electric models planned by global automakers for China, where the government is pressing them to accelerate development of the technology. (AP Photo/Vincent Yu) Manufacturers including General Motors and Volkswagen are poised this year to launch a flood of electric sedans, minivans and SUVs in China designed for local tastes and smaller budgets. Nissan, Tesla, GM and others sell imported electrics or electrified versions of models made by Chinese partners, but the market is dominated by low-cost local rivals including BYD Auto.China’s government sees electric cars as a promising industry and a way to clean up its smog choked cities. It has spent heavily on subsidies to Chinese producers and is shifting the burden to automakers with sales quotas and tougher fuel efficiency standards.The Sylphy Zero Emission, based on Nissan’s leaf, is being produced by Nissan Motor Co. and a Chinese partner, Dongfeng Motor group.The Sylphy costs 166,000 yuan ($25,850) after government subsidies, or just over half the sticker price of the Chinese version of the Leaf sold by Nissan and Dongfeng’s joint venture Venucia brand. Nissan says the Sylphy can go 338 kilometers (210 miles) on a charge. Hiroto Saikawa, Nissan Motor Co., Ltd’s president and CEO, right, and Zhu Yanfeng, Chairman and Party Secretary of Dongfeng Motor Group Co., Ltd, left, pose during the launching of the Nissan Sylphy Zero Emission, the Nissan’s first all-electric vehicle built in China, in China, in Guangzhou, Guangdong province, China, Monday, Aug. 27, 2018. The Sylphy is part of a wave of dozens of electric models planned by global automakers for China, where the government is pressing them to accelerate development of the technology. (AP Photo/Vincent Yu) A worker of Dongfeng Nissan, right, wears a uniform with a pin with Chinese words “Communist party member” attends the ceremony of launching Nissan Sylphy Zero Emission, the Nissan’s first all-electric vehicle built in China, in Guangzhou, Guangdong province, China, Monday, Aug. 27, 2018. The Sylphy is part of a wave of dozens of electric models planned by global automakers for China, where the government is pressing them to accelerate development of the technology. (AP Photo/Vincent Yu) 5 things to know about Tesla’s China plans Hiroto Saikawa, Nissan Motor Co., Ltd’s president and CEO, right, and Zhu Yanfeng, Chairman and Party Secretary of Dongfeng Motor Group Co., Ltd, left, attend the ceremony of the launching of the Nissan Sylphy Zero Emission, the Nissan’s first all-electric vehicle built in China, in Guangzhou, Guangdong province, China, Monday, Aug. 27, 2018. The Sylphy is part of a wave of dozens of electric models planned by global automakers for China, where the government is pressing them to accelerate development of the technology. (AP Photo/Vincent Yu) The Chinese government announced in April it would end restrictions on foreign ownership of electric vehicle manufacturers this year in an effort to promote development.Producers including GM and Nissan had been reluctant to transfer manufacturing to China due to the requirement to share technology with Chinese partners that might become rivals.Freed of that requirement, Tesla Inc. announced in July it would build its first factory outside the United States in Shanghai, becoming the first wholly foreign-owned automaker in China.Other automakers are working through ventures with Chinese partners, hoping to take advantage of their experience at developing lower-cost vehicles.Chinese sales in July of pure electric and gasoline-electric hybrids, boosted by subsidies and other government support, rose 47.7 percent over a year to 84,000. © 2018 The Associated Press. All rights reserved. “By the end of this year, things will be different,” said Zhang. “We really will see the market become more competitive and consumers will have more to choose.”Government plans call for total annual sales of 2 million electric and gasoline-electric hybrid vehicles by 2020, up from last year’s 770,000. Workers of the Dongfeng Nissan attend the ceremony launching the Nissan Sylphy Zero Emission, the Nissan’s first all-electric vehicle built in China, in Guangzhou, Guangdong province, China, Monday, Aug. 27, 2018. The Sylphy is part of a wave of dozens of electric models planned by global automakers for China, where the government is pressing them to accelerate development of the technology. (AP Photo/Vincent Yu) Hiroto Saikawa, Nissan Motor Co., Ltd’s president and CEO, right, and Zhu Yanfeng, Chairman and Party Secretary of Dongfeng Motor Group Co., Ltd, left, attend the ceremony of the launching of the Nissan Sylphy Zero Emission, the Nissan’s first all-electric vehicle built in China, in Guangzhou, Guangdong province, China, Monday, Aug. 27, 2018. The Sylphy is part of a wave of dozens of electric models planned by global automakers for China, where the government is pressing them to accelerate development of the technology. (AP Photo/Vincent Yu) A cameraman takes video of a Nissan Sylphy Zero Emission, the Nissan’s first all-electric vehicle built in China, at the Nissan factory in Guangzhou, Guangdong province, China, Monday, Aug. 27, 2018. The Sylphy is part of a wave of dozens of electric models planned by global automakers for China where the government is pressing them to accelerate development of the technology. (AP Photo/Vincent Yu) This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only. GM says it will roll out 10 electric and hybrid models in China from 2016 to 2020. It says 2025, all its Buick, Cadillac and Chevrolet models in China will offer hybrid or pure-electric versions.Tesla says China is its second-largest market. But a high sticker price has limited sales by other foreign brands to a few hundred vehicles. Citation: Nissan launches China-focused electric car (2018, August 27) retrieved 18 July 2019 from https://phys.org/news/2018-08-nissan-china-focused-electric-car.html Nissan’s first electric sedan designed for China began production Monday at the start of a wave of dozens of planned lower-cost electrics being created by global automakers for their biggest market. Chinese workers inspect a Nissan Sylphy Zero Emission, Nissan’s first all-electric vehicle built in China, at a production line in Guangzhou, Guangdong province, China, Monday, Aug. 27, 2018. The Sylphy is part of a wave of dozens of electric models planned by global automakers for China, where the government is pressing them to accelerate development of the technology. (AP Photo/Vincent Yu) Explore further A worker inspects a Nissan Sylphy Zero Emission, Nissan’s first all-electric vehicle built in China, at a production line in Guangzhou, Guangdong province, China, Monday, Aug. 27, 2018. The Sylphy is part of a wave of dozens of electric models planned by global automakers for China where the government is pressing them to accelerate development of the technology. (AP Photo/Vincent Yu) “We’re confident that the Sylphy Zero Emission rolling off the production line today will become a main player in the EV market,” said Nissan CEO Hiroto Saikawa. “We’re going to roll out a range of EVs that will appeal to customers within all market segments.”Sales quotas that take effect next year require every brand to sell electrics or buy credits from competitors that do. That puts pressure on automakers to create models Chinese consumers want and can afford.China accounted for half of global electric car sales last year, but almost all of those came from Chinese brands including BYD Auto and BAIC Group. Their prices start as low as 140,000 yuan ($22,000).”Basically, all these international giants are testing the water. They have not really launched their heavyweight models in China yet,” said industry analyst Yale Zhang of Automotive Foresight.
Interactive control to guide industrial robots The Hannover Messe showcase is a collaboration between the Fraunhofer Cluster of Excellence Cognitive Internet Technologies (www.cit.fraunhofer.de), Volkswagen and the Fraunhofer Institute for Integrated Circuits IIS. “Knowledge related to Berlin has been collated into a knowledge graph, where each building represents a point on the graph and forms connections with other points. As a result, we can gather progressively more information and constantly expand the knowledge base. This is what allows answering complex questions instead of restricting inquiries to a limited number of prescribed questions,” explains Lehmann. In a manufacturing context, this sort of knowledge graph could report on the status of machines, for example, or answer questions about components produced in the last hour. The knowledge graphs used for the trade show exhibition draw on a variety of data sources including Dbpedia (http://dbedia.org) and OpenStreetMap. A special feature of the voice assistant is that it is also able to harness unstructured knowledge, such as text documents on museums, for instance.With these systems, you have not only the physical machine in the production hall, but also a virtual counterpart that is fed with real data. This data can be interrogated using dialog or question answering systems. “While question answering systems directly answer a single question, dialogue systems support multiple interaction steps with sequences of questions and answers. A dialog system will also respond to sequences of inquiries and small talk, just like the exhibit we will have on display,” says Lehmann.The more training data, the smarter the voice assistant”It is the domain-specific knowledge that makes a voice assistant smart. The technical challenge from our side lies in developing a system that can understand users’ queries and respond appropriately using the knowledge contained in the knowledge graph,” the researcher concludes. Developing such a system calls for the application of the latest techniques in machine learning, techniques that the researchers at Fraunhofer IAIS are constantly developing and refining. The expertise they have assembled in machine learning and domain-specific knowledge puts them at the top of their field internationally. Tailored to the respective domains, the experts select the appropriate machine learning algorithms and train them using sample dialogs and question-answer pairs. The intelligence of the voice assistant grows with the amount of training data it amasses. The voice assistants developed by Fraunhofer IAIS offer their users the ultimate digital experience and are all GDPR-compliant. Visitors can try out the exhibition demonstrator live at the Hannover Messe from April 1 to 5 at the Fraunhofer Booth C22 in Hall 2. Voice assistants are becoming more and more prevalent in every area of our lives. At this year’s Hannover Messe, researchers from the Fraunhofer Institute for Intelligent Analysis and Information Systems IAIS are teaming up with au-tomaker Volkswagen to showcase a new voice interaction system that caters to domain-specific knowledge. Drawing on the techniques of “informed” machine learning, the system goes far beyond the capabilities of most Alexa, Siri & co. skills – and has been specifically designed for use in industry. The smart vehicle voice assistant is an example of how companies can use dialog systems to enable users to interact intuitively with technology and to develop new busi-ness models. The system will be on display – in a VW Tiguan – from April 1 to 5 at the Fraunhofer Booth C22 in Hall 2. Explore further Provided by Fraunhofer-Gesellschaft Many people use Alexa, Siri and other similar voice assistants on a daily basis, dipping in to access the latest news, make use of voice navigation or simply stream their favorite songs. Voice assistants are an intuitive way to interact with technology, an effective way of delivering services and imparting information. They are not just handy everyday helpers, however; they present companies and business with a huge opportunity to simplify human-machine interaction and offer entirely new services to their industry customers.Focus on companiesResearchers at Fraunhofer IAIS in Sankt Augustin develop just these sorts of voice interaction systems for use in a wide variety of applications, including manufacturing and the automotive and medical sectors. While Alexa, Siri and the like are aimed at individual consumers, the research team at Fraunhofer IAIS uses the latest techniques in machine learning, question answering and knowledge graphs to address the specific needs and challenges of business. “In manufacturing, for instance, we are seeing more and more robots equipped with voice assistants, which the worker can then operate and train using voice and gestures,” says Prof. Dr. Jens Lehmann, Lead Scientist at Fraunhofer IAIS.Prof. Lehmann and his team at Fraunhofer IAIS specialize in dialog systems catering to domain-specific knowledge and trained for specific applications. At the Hannover Messe, they will be showcasing a voice assistant integrated into a VW Tiguan. Wearing a headset and virtual reality glasses, drivers will be taken on a virtual tour of Berlin while the interactive system answers questions about the surroundings such as: What’s that building on the left-hand side? What’s it known for? When was it built? Who built it? The system also supports supplementary questions such as “Where does the architect come from?” or “Tell me more about him!”Domain-specific knowledge answering complex questions Fraunhofer IAIS’s new dialog system can answer complex questions – including queries from drivers about their surroundings. The voice assistant can be used in a wide variety of applications, including manufacturing and the medical sector. Credit: iStock Citation: Smart voice assistant answers your questions (2019, March 1) retrieved 17 July 2019 from https://phys.org/news/2019-03-smart-voice.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
SHARE SHARE EMAIL COMMENTS CBI SHARE February 06, 2019 COMMENT New Delhi, February 6The government is not seriously contemplating bringing extensive reforms in the Central Bureau of Investigation (CBI), Minister of State for Personnel Jitendra Singh said on Wednesday. “No,” said the minister in a written reply in Lok Sabha when a question on the same was asked. The assertion assumes significance as the central probe agency had been in news for some time due to bitter fight between its two former top officers — former CBI chief Alok Kumar Verma and the then Special Director Rakesh Asthana.Both Verma and Asthana had accused each other of corruption. PTIMeanwhile, the government had on Saturday appointed former Madhya Pradesh police chief Rishi Kumar Shukla as CBI chief. Published on
NEW DELHI: A fortnight before publication of the final National Register of Citizens (NRC) in Assam, the Centre and state government on Tuesday moved the Supreme Court seeking re-verification of 20% of draft NRC data while claiming that exclusion of Indian citizens and inclusion of illegal Bangladeshi migrants in the draft had come to notice. The SC has set July 31 as the deadline for publication of the final NRC. The Centre and Assam government backed up their plea by recalling that the SC had itself in August last year favoured re-verification of 10% of the entries in the NRC. “We are of the view that the court should consider the necessity of carrying out sample re-verification of at least 10% of the names included in the final draft NRC, if required by a team of NRC Seva Kendra personnel from a neighbouring district,” the apex court had said on August 28 last year. Citing this, solicitor general Tushar Mehta mentioned the applications before a bench headed by CJI Ranjan Gogoi and sought urgent hearing. The CJI said, “NRC state coordinator (Prateek Hajela) has also filed a report. But the deadline for publication of final NRC is July 31.” The SG said if the applications could be listed before the deadline, the government would explain the need for re-verification of draft NRC data and then abide by whatever the SC decided. The two applications by the Centre and Assam made identical prayers, “Pass an order directing 20% sample re-verification of names included in the final draft NRC in the districts of Assam bordering Bangladesh and 10% sample re-verification of names included in the final draft NRC in the remaining districts. Pass appropriate directions thereby fixing the place for sample re-verification at a place not being in the vicinity of initial NRC verification so as to rule out possibility of local influences, bias, threat etc.” According to the Assam government, many original inhabitants of the state found their names excluded as they lacked documents and did not even apply for inclusion in NRC. As against this, many of those detected and declared to be foreigners by tribunals had been included in the draft NRC. Not just that, many of those determined to be foreigners were working as NRC officers, the state government claimed. It accused NRC officials of including foreigners in the register in exchange for bribes, and pointed out that while districts bordering Bangladesh had recorded a higher rate of inclusion, those dominated by original inhabitants had witnessed a higher rate of exclusion. The final draft NRC, published in August last year, had excluded over 40 lakh people. The state NRC coordinator’s office has so far received 36.2 lakh applications for inclusion of names, and another 2 lakh applications seeking exclusion of names. NGO ‘Assam Public Works’, on whose petition the SC started monitoring NRC work six years ago, has also filed an application seeking 100% re-verification of names included in the final draft in 22 districts of the state while highlighting the arrest of two NRC officials, who were seeking bribe from an applicant for inclusion in the final NRC. In Video:Assam: Government extends NRC deadline by one month to July 30Download The Times of India News App for Latest India News.XStart your day smart with stories curated specially for you